Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine
- 1 October 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 81 (4) , 591-595
- https://doi.org/10.1016/0002-9343(86)90542-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Epidemiology and Clinical Impact of Hepatitis D Virus (Delta) InfectionHepatology, 1985
- Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of EfficacyAnnals of Internal Medicine, 1984
- Immune response to hepatitis B vaccine in drug addictsJournal of Infection, 1983
- Infection with Delta Agent in Sweden: Introduction of a New Hepatitis AgentThe Journal of Infectious Diseases, 1982
- OCCUPATIONAL EXPOSURE TO HEPATITIS B VIRUS IN HOSPITAL PERSONNEL: INFECTION OR IMMUNIZATION?American Journal of Epidemiology, 1982
- MULTICENTRE STUDY OF PREVALENCE OF HBV-ASSOCIATED DELTA INFECTION AND LIVER DISEASE IN DRUG-ADDICTSThe Lancet, 1982
- Interpretation of Various Serological Profiles of Hepatitis B Virus InfectionAmerican Journal of Clinical Pathology, 1981
- Hepatitis B VaccineNew England Journal of Medicine, 1980
- INCIDENCE AND SIGNIFICANCE OF ANTIBODIES TO DELTA ANTIGEN IN HEPATITIS B VIRUS INFECTIONThe Lancet, 1979
- Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative studyThe Lancet Healthy Longevity, 1975